In contrast with FMF, SURF, PFAPA patients and HD showed the following features: i) UCN-01 mediated-pyrin dephosphorylation was not sufficient to trigger Pyrin inflammasome activation; ii) the in vitro colchicine administration caused a huge inhibition of TcdA-induced pyrin inflammasome activation. This evidence concerns the gene MEFV and PFAPA syndrome.